Authors:
GIACALONE PL
TARGOSZ V
LAFFARGUE F
BOOG G
FAURE JM
Citation: Pl. Giacalone et al., CERVICAL RIPENING WITH MIFEPRISTONE BEFORE LABOR INDUCTION - A RANDOMIZED STUDY, Obstetrics and gynecology, 92(4), 1998, pp. 487-492
Authors:
FAURE JM
GIACALONE PL
DESCHAMPS F
BOULOT P
Citation: Jm. Faure et al., NONIMMUNE HYDROPS-FETALIS CAUSED BY INTRAUTERINE HUMAN PARVOVIRUS B19INFECTION - A CASE OF SPONTANEOUS REVERSAL IN-UTERO, Fetal diagnosis and therapy, 12(2), 1997, pp. 66-67
Authors:
GIACALONE PL
LAFFARGUE F
BENOS P
ROUSSEAU O
HEDON B
Citation: Pl. Giacalone et al., CISPLATINUM NEOADJUVANT CHEMOTHERAPY IN A PREGNANT WOMAN WITH INVASIVE-CARCINOMA OF THE UTERINE CERVIX, British journal of obstetrics and gynaecology, 103(9), 1996, pp. 932-934
Authors:
LAFFARGUE F
GIACALONE PL
BOULOT P
VIGOUROUX B
HEDON B
BENOS P
Citation: F. Laffargue et al., A LAPAROSCOPIC PROCEDURE FOR THE TREATMENT OF VAGINAL APLASIA, British journal of obstetrics and gynaecology, 102(7), 1995, pp. 565-567
Authors:
GIACALONE PL
BENOS P
DONNADIO D
LAFFARGUE F
Citation: Pl. Giacalone et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY METASTATIC GESTATIONAL TROPHOBLASTIC DISEASE, Gynecologic oncology, 58(3), 1995, pp. 383-385
Authors:
BONNIER P
ROMAIN S
GIACALONE PL
LAFFARGUE F
MARTIN PM
PIANA L
Citation: P. Bonnier et al., CLINICAL AND BIOLOGIC PROGNOSTIC FACTORS IN BREAST-CANCER DIAGNOSED DURING POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY, Obstetrics and gynecology, 85(1), 1995, pp. 11-17
Citation: Pl. Giacalone et F. Laffargue, HORMONAL REPLACEMENT THERAPY AFTER BREAST -CANCER, Contraception fertilite sexualite, 22(12), 1994, pp. 741-745